NCT05046379Completed
Studying Lipids as Potential Biomarkers in Patients With Fabry Disease
Lipidomics for Identification of New Biomarkers for Fabry Disease
Source: ClinicalTrials.gov · Last updated 1 Oct 2024
Brief summary (registry, in English)
Compare levels of lipids between well characterised enzymatically-genetically-phenotypically patients with Fabry disease and healthy controls (with no Fabry disease). Correlate levels of lipids in patients with Fabry disease to clinical outcomes/manifestations of the disease.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 108 (actual)
- First submitted
- 6 Sept 2021
- Start date
- 14 Oct 2021
- Primary completion date
- 28 Apr 2024
- Lead sponsor
- Vastra Gotaland Region
- Diseases
- Fabry disease
- NCT number
- NCT05046379
What you commit to
- Study type: Observational
- Participants enrolled: 108
- From 14 Oct 2021 to the primary completion date, 28 Apr 2024
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Fabry disease
- Ongoing infection
Lab values
- Liver disease with elevated transaminases
Who the study is looking for
- Adult men and women
- Well characterized Fabry disease in terms of i. alpha-Gal A enzyme activity, ii. mutation in alpha-Gal A (GLA) gene, and iii. disease manifestations
- Followed at one of the 3 centers for patients with Fabry disease in Sweden (Karolinska in Stockholm, Sahlgrenska in Gothenburg, Akademiska in Uppsala)
- Signed informed consent prior to sample collection is mandatory for inclusion to the study.
- Adult men and women
- Followed/treated at the endocrinology or nephrology in- or out-patient clinic at Sahlgrenska University Hospital in Gothenburg
- Matched for age, sex, estimated Glomerular filtration rate (eGFR) with the cases with Fabry disease
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sahlgrenska University Hospital Coordinator of this site? Confirm its status | Gothenburg | Sweden | Unknown status |
| Karolinska University Hospital Coordinator of this site? Confirm its status | Stockholm | Sweden | Unknown status |
| Akademiska University Hospital Coordinator of this site? Confirm its status | Uppsala | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.